Achieve rapid, sustainable improvements in hypertension control
AMA MAP™ Hypertension is a leading evidence-based quality improvement (QI) program that provides a clear path to significant, sustained improvements in blood pressure (BP) control.
AMA MAP Hypertension puts your organization ahead of the curve
High-impact results
AMA MAP Hypertension has demonstrated a 10 percentage
point increase in BP control in 6 months with
sustained results at 1 year1
Access to powerful data and metrics
Track your organization's progress and enhance
your reporting capabilities with the easy-to-use
AMA MAP Hypertension Dashboard
Guidance from AMA experts
AMA hypertension and quality improvement
experts are here to help guide you through—at no
charge to your organization
Proven value for health care organizations
Meaningful improvement in clinical outcomes may
lead to improved quality scores and
opportunities for streamlined reimbursement
Program Details
What is AMA MAP Hypertension?
Rapid, sustained BP improvements
With AMA MAP Hypertension, HCOs have increased BP control rates quickly. The program has demonstrated a 10% increase in BP control in 6 months with sustained results at 1 year.1 Meaningful outcomes such as these may also lead to the improvement of quality scores and opportunities for streamlined reimbursement.
Improving BP control system-wide
AMA MAP Hypertension is developed to help larger HCOs rapidly improve BP control in larger patient populations, which can significantly reduce heart attacks, stroke, heart failure and end stage renal disease. The AMA provides this program to HCOs at no charge.
Reducing risk factors saves lives
In the United States, hypertension is a leading cause of heart disease, which is the leading cause of death. Effective BP control can significantly reduce heart attacks, stroke, heart failure and end stage renal disease.2
Partnership from step one
AMA leaders in hypertension control and change management will collaborate with your team to implement AMA MAP Hypertension.
Planning your route and guiding the way
AMA experts will first gain an understanding of the unique resources and needs of your organization. Through this groundwork, a multidisciplinary team at your HCO will be identified and roles will be defined to ensure adoption, support and implementation of the program.
Brent M. Egan, Susan E. Sutherland, Michael Rakotz, Jianing Yang, R. Bruce Hanlin, Robert A. Davis, Gregory Wozniak. Improving Hypertension Control in Primary Care with the Measure Accurately, Act Rapidly and Partner with Patients (MAP) Protocol: Results at 6 and 12 Months. Hypertension. 2018;72:1320–1327. https://doi.org/10.1161/HYPERTENSIONAHA.118.11558
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71:e42,e50,e61,e64. https://doi.org/10.1161/HYP.0000000000000065
How MAP works
AMA's framework for results
Each component of the MAP framework incorporates evidence-based strategies, action steps, tools, resources and more to drive meaningful outcomes.
Measure
Accurately
Act
Rapidly
Partner
with Patients
How MAP works
AMA's framework for results
Each component of the MAP framework incorporates evidence-based strategies, action steps, tools, resources and more to drive meaningful outcomes.
Measure Accurately
Improper BP measurement technique can affect BP readings by -9 to +23 mm Hg3. Applying best practices addresses possible current gaps in BP measurement.
Key Metric
Confirmatory BP
Act Rapidly
A key barrier to BP control is the lack of BP medication intensification in a timely manner. Controlling BP in under 6 months and sustained control are linked with better outcomes than slower and intermittent control.4
Key Metric
Therapeutic Intensity
Partner with Patients
Ensuring patients are engaged in their care is key for success. Using evidence-based communication skills such as open-ended questions and teach-back can reveal patient barriers and improve self-care.
Key Metric
SBP Change After Therapeutic Intensification
Visit Follow-up
Progress is tracked through a comprehensive metric:
Overall Outcome
Improved BP Control
Expertise, tools, resources, and support
Each MAP component incorporates:
- An evidence-based strategy and action steps
- Supporting tools and resources
- QI and clinical implmentation guidance
- Performance metrics, dashboards and monthly reports
Charting your course for success
The program's evidence-based framework is just the beginning. An easy-to-use dashboard ensures your HCO has access to the most relevant patient data so you can enhance BP care management for your patients.
Padwal R, Campbell NRC, Schutte AE, Olsen MH, Delles C, Etyang A, Cruickshank JK, Stergiou G, Rakotz MK, Wozniak G, Jaffe MG, Benjamin I, Parati G, Sharman JE. Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group. J Hypertens. 2019 Sep;37(9):1737-1745. doi: 10.1097/HJH.0000000000002112. PMID: 31034450; PMCID: PMC6686964.
Miriampillai JE, Eskas PA, Heimark S, Kjeldsen SE, Narkiewwicz K, Mancia G. A case for less intensive blood pressure control: it matters to achieve target blood pressure early and sustained below 140/ 90 mmHg. Prog Cardiov Dis 2016; 59:209–218.
What health care organizations are saying
"AMA MAP [Hypertension] is structured but flexible and recruits all members of the health care team from practice leadership to providers to nurses to IT to facilities staff to, mostly importantly, patients."
"AMA MAP [Hypertension] offers well defined resources and a strong team of experts to assist with implementation across practice settings."
"Through the AMA MAP [Hypertension] collaboration, our organization has seen more accurate blood pressure readings which has allowed for more aggressive treatment of blood pressures with less inertia and overall better control rates."
Frequently asked questions
Answers to some of the most common questions
about AMA MAP Hypertension
Why should improvement of BP control be a priority for my HCO now?
Improving BP control is one of the most effective ways to improve patient health within your HCO. Hypertension significantly increases the risks of heart, brain, kidney and other diseases. Together, these conditions contribute to nearly 850,000 deaths annually in the United States—many that could be prevented with better blood pressure control.2
In the United States, blood pressure control has been declining over the last 5 years. Now, less than half of adults with hypertension have it controlled.
AMA MAP BP is shown to increase BP control rates by 10 percentage points in 6 months with sustained results at 1 year.1 These improved high blood pressure outcomes may lead to better quality scores and opportunities for streamlined reimbursement.
What resources does the AMA provide as part of AMA MAP Hypertension?
In collaboration with your organization’s leadership, quality improvement, information technology, clinical and operations teams, the AMA will provide planning and support during program setup and implementation, which can include the AMA MAP Hypertension Dashboard, to help your organization reach its desired objectives.
AMA experts will provide coaching to help:
- Train and assist your clinical team on AMA MAP Hypertension. With ongoing communication and support from AMA, designated clinical team members will serve as practice coaches to implement the program
- Co-lead a kickoff event presentation(s) with your faculty, assisting in the creation of content for these events
- Assist in assessing your practice sites’ readiness to implement the program
- Assist in evaluating and developing a plan for ongoing improvement and spreading it throughout your HCO
- Support your clinical team(s) throughout the implementation process
- Share observations and insights as appropriate
AMA experts also provide support with the AMA MAP Hypertension Dashboard:
- Provide analytics and technical support to incorporate AMA MAP Hypertension performance metrics into new or existing dashboards or data distribution processes
- Collaborate to validate data in performance metrics
- Collaborate to analyze performance metrics and provide a dashboard with aggregate results for your leadership teams and actionable, patient-level information for the clinical team
What does it cost to participate in this program?
The resources offered by the AMA as part of the program are provided at no cost to HCOs. To implement the program, HCOs can expect to incur equipment costs if the decision is made to purchase new BP measurement devices as well as incremental allocations in clinical, quality improvement and information technology staffing.
What health systems do you currently work with?
We are working with dozens of HCOs, including federally qualified health centers, academic medical centers and some of the largest multi-state health systems in the United States.
Ready to put your HCO on the map?
Get in touch today
Let us know you're interested in learning more about AMA MAP BP. We'll connect with you and help determine if this program is right for your organization.
Get StartedBrent M. Egan, Susan E. Sutherland, Michael Rakotz, Jianing Yang, R. Bruce Hanlin, Robert A. Davis, Gregory Wozniak. Improving Hypertension Control in Primary Care with the Measure Accurately, Act Rapidly and Partner with Patients (MAP) Protocol: Results at 6 and 12 Months. Hypertension. 2018;72:1320–1327. https://doi.org/10.1161/HYPERTENSIONAHA.118.11558
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71:e42,e50,e61,e64. https://doi.org/10.1161/HYP.0000000000000065
Padwal R, Campbell NRC, Schutte AE, Olsen MH, Delles C, Etyang A, Cruickshank JK, Stergiou G, Rakotz MK, Wozniak G, Jaffe MG, Benjamin I, Parati G, Sharman JE. Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group. J Hypertens. 2019 Sep;37(9):1737-1745. doi: 10.1097/HJH.0000000000002112. PMID: 31034450; PMCID: PMC6686964.
Miriampillai JE, Eskas PA, Heimark S, Kjeldsen SE, Narkiewwicz K, Mancia G. A case for less intensive blood pressure control: it matters to achieve target blood pressure early and sustained below 140/ 90 mmHg. Prog Cardiov Dis 2016; 59:209–218.